41 reports

  • SMOKING CESSATION AIDS
  • Smoking Cessation Aids Sales Volume by

China’s demand for Smoking Cessation Aids has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...

  • Smoking Cessation
  • China
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • Smoking Cessation Aids Sales Volume by
  • Smoking Cessation Aids Export by Classification

This study focuses on China’s Smoking Cessation Aids industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s...

  • Smoking Cessation
  • China
  • Demand
  • Trade
  • GlaxoSmithKline plc

Smoking Cessation and Nicotine De-Addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023 ##.

  • OTC
  • Smoking Cessation
  • World
  • Market Size
  • SMOKING CESSATION AIDS
  • Smoking Cessation Aids Industry Structure

This study focuses on China’s Smoking Cessation Aids industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China...

  • Smoking Cessation
  • China
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • NRT SMOKING CESSATION AIDS IN COLOMBIA - CATEGORY ANALYSIS
  • September 2016

NRT smoking cessation aids posted slow current value growth of 1% in 2016, to reach Col$3.3 billion. In Colombia smoking prevalence continues to decline, and by 2016 it is estimated that the prevalence of smokers will be 13% of the total adult population, which is one percentage point below the rate recorded at the beginning of the review...

  • OTC
  • Smoking Cessation
  • Colombia
  • Demand

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • Smoking Cessation
  • France
  • Germany
  • United States
  • Market Size

Global Market Study on Smoking Cessation and Nicotine De-addiction Products: Electronic Cigarette Product Type Segment to Register a Value CAGR of ##. ##% During the Forecast Period 2017 - 2025 ##.

  • Smoking Cessation
  • APAC
  • North America
  • World
  • Market Size
  • GLOBAL SMOKING CESSATION MARKET 2016-2021 ($ BILLIONS)
  • Global smoking cessation market 2016: $7.12 billion

About Tobacco Alternative Gums Tobacco alternative gums are products such as nicotine gums, which are used by smokers to quit smoking. Nicotine gum is a smoking cessation product, which helps smokers to gradually get off nicotine. Nicotine released from chewing nicotine gum is absorbed into the bloodstream through the lining...

  • Smoking Cessation
  • United States
  • World
  • GlaxoSmithKline plc
  • Novartis AG
  • NJOY IN GLOBAL SMOKING CESSATION PRODUCTS MARKET
  • GLOBAL SMOKING CESSATION PRODUCTS MARKET BY TYPE

About Smoking Cessation Products Smoking cessation products such as NRTs and e-cigarettes have proved useful in reducing the numbers of smokers worldwide. They can also be used to reduce smoking. A substantial number of smokers are now either quitting or trying to reduce smoking. This is because of increased awareness about the adverse...

  • Smoking Cessation
  • GlaxoSmithKline plc
  • ITC Limited
  • Pfizer Inc.
  • Reynolds American Inc.

Smoking Cessation Products - Market Trends & Insights ##.

  • OTC
  • Smoking Cessation
  • World
  • Demand
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • Smoking Cessation
  • France
  • Germany
  • Italy
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • United States
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • Japan
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • France
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • United Kingdom
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • Germany
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • Italy
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • Spain
  • Market Size
  • Smoking cessation products market in the US 2016-2021 ($ billions)
  • Segmentation of market by products

About Herbal Cigarette Herbal cigarettes are nicotine-free and tobacco-free cigarettes that use a mixture of various herbs instead of tobacco. Smoking can be linked to more number of fatalities than the combined number of deaths caused by motor vehicle injuries, illegal drug use, alcohol use, human immunodeficiency virus (HIV),...

  • Smoking Cessation
  • United States
  • Demand
  • Forecast
  • Market Size
  • Nicotine Gum Market 2016-2022 ($ million)
  • 12.2 NICOTINE GUM

Functional chewing gums have some added health benefits and ingredients that impart additional functions instead of traditional fresh-breathing function. Nicotine gums, oral health gums, weight management gums, and lifestyle gums are some of the most common types of functional chewing gum. The global functional chewing gum market is...

  • Smoking Cessation
  • World
  • Market Size
  • Mondelez International, Inc.
  • Wrigley, S.A.

INTRODUCTION.............. ## ##.

  • OTC
  • Smoking Cessation
  • World
  • Demand
  • Market Size
  • JANSSEN-CILAG OY

Jansen-Cilag Oy aims to be a leading player in Finnish OTC consumer health with a strategy built on offering products of high quality and the development of a loyal consumer base. Its core interest lies in NRT smoking cessation aids, with the Nicorette brand. Janssen-Cilag is expected to focus on NRT smoking cessation aids over the forecast...

  • OTC
  • Smoking Cessation
  • Finland
  • Demand
  • Forecast
  • Smoking Cessation Products
  • Seven: Smoking Cessation Products

Over the past 38 years the U.S. Rx-to-OTC market has grown into a $7.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide...

  • Smoking Cessation
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Challenges and Opportunities Facing Nrt Smoking Cessation Aids
  • Nicorette Nrt Smoking Cessation Aids Now Available on General Sale

Calming and sleeping in Ireland continues to face restrictions on the sale of products other than those containing herbal/traditional ingredients. While recent years have seen an increase in products and brand variations available in the category, with additional products positioned towards encouraging sleep or relieving exam stress, for example,...

  • Smoking Cessation
  • Ireland
  • Demand
  • Kelkin Ltd
  • Reckitt Benckiser Group plc
  • MCNEIL DENMARK APS
  • Passport 2

ONE OF THE REASONS BEHIND THIS WAS THAT MCNEIL DENMARK' S SHARE IN NRT SMOKING CESSATION AIDS, WHICH ACCOUNTED FOR ##% OF THE COMPANY TOTAL VALUE SALES IN 2016, HAS BEEN LOSING SHARE IN RECENT YEARS.

  • OTC
  • Smoking Cessation
  • Denmark
  • Demand
  • Market Competition

Smoking Cessation Pipeline Highlights – 2017 ##.

  • OTC
  • Pharmaceutical
  • Smoking Cessation
  • United States
  • Product Initiative

Smoking Cessation - Pipeline Insight, 2018 ##.

  • Pharmaceutical
  • Smoking Cessation
  • Therapy
  • Nov 11, 2013: Change to FDA reviewing division for smoking cessation clinical trial
  • Jan 12, 2012: Inverseon Focuses On Smoking Cessation As Initial Indication For INV102

Smoking Addiction - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Smoking Addiction - Pipeline Review, H2 2017, provides an overview of the Smoking Addiction (Central Nervous System) pipeline landscape. Smoking is addictive,...

  • Pharmaceutical
  • Smoking Cessation
  • United States
  • Product Initiative
  • Invion Limited
  • Nov 11, 2013: Change to FDA reviewing division for smoking cessation clinical trial
  • Feb 02, 2015: Invion completes enrolment in its phase II trial of oral INV102 (nadolol) in smoking cessation

Smoking Addiction - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Smoking Addiction - Pipeline Review, H1 2017, provides an overview of the Smoking Addiction (Central Nervous System) pipeline landscape. In smoking addiction, people experience...

  • Pharmaceutical
  • Smoking Cessation
  • Therapy
  • United States
  • Product Initiative

Smoking Cessation - Pipeline Review, H## 2015 Table of Contents Table of Contents ## List of Tables ## List of Figures ## Introduction ## Global Markets Direct Report Coverage ## Smoking Cessation Overview ## Therapeutics Development ## Pipeline Products for Smoking Cessation - O

  • OTC
  • Pharmaceutical
  • Smoking Cessation
  • Therapy